Effects of PCSK9 Inhibition on Coronary Atherosclerosis Regression of Nontarget Lesions after Primary Percutaneous Coronary Intervention in Acute Coronary Syndrome Patients.
Yongjun LiMingming YangXi ChenRui ZhangJing LiXiaoguo ZhangPengfei ZuoGenshan MaPublished in: Journal of interventional cardiology (2022)
After 1 year of PCSK9 inhibition treatment for ACS patients, the area stenosis of non-TLR was considerably reduced.
Keyphrases
- acute coronary syndrome
- end stage renal disease
- percutaneous coronary intervention
- ejection fraction
- chronic kidney disease
- newly diagnosed
- coronary artery disease
- peritoneal dialysis
- coronary artery
- type diabetes
- antiplatelet therapy
- patient reported outcomes
- aortic stenosis
- transcatheter aortic valve replacement
- st elevation myocardial infarction
- combination therapy
- patient reported